PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in PMV Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- +1 vs. Q4 2023
- Shares held
- 42.7M
- −3.72M (−8.0%) vs. Q4 2023
- Total value
- $72.7M
- −$71.3M (−49.5%) vs. Q4 2023
- New holders
- 16
- 35 more added
- Sold out
- 15
- 26 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMVP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 64 | $45.9M |
| Q1 2026 | 69 | $45.8M |
| Q4 2025 | 63 | $46.8M |
| Q3 2025 | 64 | $52.5M |
| Q2 2025 | 54 | $36.8M |
| Q1 2025 | 55 | $40.7M |
| Q4 2024 | 70 | $58.8M |
| Q3 2024 | 74 | $58.2M |
| Q2 2024 | 93 | $65.6M |
| Q1 2024 | 99 | $72.7M |
| Q4 2023 | 98 | $144.0M |
| Q3 2023 | 104 | $333.0M |
| Q2 2023 | 106 | $324.0M |
| Q1 2023 | 113 | $245.7M |
| Q4 2022 | 115 | $474.5M |
| Q3 2022 | 120 | $692.3M |
| Q2 2022 | 105 | $870.9M |
| Q1 2022 | 99 | $1.15B |
| Q4 2021 | 105 | $1.10B |
| Q3 2021 | 92 | $1.31B |
| Q2 2021 | 86 | $1.44B |
| Q1 2021 | 81 | $1.31B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding PMV Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −685,985−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −685,985−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −72,683−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −33,900−100.0% | Sold out |
| Aristides Capital LLC | 0 | $0 | 0.00% | −31,145−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −22,915−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −20,994−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,442−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −11,322−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −11,221−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −11,134−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |